Quantcast
Home > Quotes > CUR

Neuralstem, Inc. Common Stock (CUR) Quote & Summary Data

CUR 
$1.1
*  
0.06
5.17%
Get CUR Alerts
*Delayed - data as of Jun. 22, 2018 13:53 ET  -  Find a broker to begin trading CUR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CUR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.07 / $ 1.10
1 Year Target
Today's High / Low
$ 1.12 / $ 1.04
Share Volume
254,543
50 Day Avg. Daily Volume
112,922
Previous Close
$ 1.16
52 Week High / Low
$ 6.60 / $ 0.88
Market Cap
16,676,015
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
254,543
50 Day Avg. Daily Volume:
112,922

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.91

Trading Range

The current last sale of $1.10 is 25.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.12 $ 6.60
 Low: $ 1.04 $ 0.88

Company Description (as filed with the SEC)

We are focused on the research and development of nervous system therapies based on our proprietary human neural stem cells and our small molecule compounds with the ultimate goal of gaining approval from the United States Food and Drug Administration or FDA, and its international counterparts, to market and commercialize such therapies. We are headquartered in Germantown, Maryland. Our patented technology platform has three core components: 1. Over 300 lines of human, regionally specific neural stem cells, some of which have the potential to be used to treat serious or life-threatening diseases through direct transplantation into the central nervous system; 2. Proprietary screening capability - our ability to generate human neural stem cell lines provides a platform for chemical screening and discovery of novel compounds against nervous system disorders; and 3.  ... More ...  

Nasdaq Official Price

Open Price:
$ 1.10
Open Date:
Jun. 22, 2018
Close Price:
$ 1.16
Close Date:
Jun. 21, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info